Carboplatin Drug Interactions
Currently displaying 273 drugs known to have a moderate interaction with carboplatin.
Moderate interactions with carboplatin
Note: Showing generic names only.
A
- adenovirus vaccine
- ado-trastuzumab emtansine
- aldesleukin
- alefacept
- allopurinol
- amikacin
- amikacin liposome
- amiodarone
- anakinra
- anisindione
- anthrax vaccine adsorbed
- atorvastatin
- auranofin
- aurothioglucose
- azathioprine
B
- bendamustine
- benznidazole
- bifidobacterium infantis
- bleomycin
- bortezomib
- brentuximab
- brewer's yeast
- bumetanide
- busulfan
C
- cabazitaxel
- canakinumab
- candida albicans extract
- capecitabine
- capreomycin
- carfilzomib
- carmustine
- cerivastatin
- cetuximab
- chlorambucil
- chloramphenicol ophthalmic
- chloramphenicol otic
- chloroquine
- cholera vaccine
- cisplatin
- clofarabine
- coccidioidin skin test
- colchicine
- colistimethate
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- crizotinib
- cyclophosphamide
- cytarabine
- cytarabine liposomal
D
- dacarbazine
- dactinomycin
- dapsone
- daunorubicin
- daunorubicin liposomal
- decitabine
- denosumab
- dexlansoprazole
- dicumarol
- didanosine
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- disulfiram
- docetaxel
- doxorubicin
- doxorubicin liposomal
E
- efalizumab
- efbemalenograstim alfa
- eflapegrastim
- elotuzumab
- elranatamab
- enfortumab vedotin
- epirubicin
- eribulin
- esomeprazole
- ethacrynic acid
- ethambutol
- ethionamide
- ethotoin
- etoposide
- etravirine
F
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
- hydralazine
- hydroxychloroquine
- hydroxyurea
I
- ibritumomab
- idarubicin
- idelalisib
- ifosfamide
- imatinib
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- iodoquinol
- ipilimumab
- isatuximab
- isoniazid
- ixabepilone
- ixazomib
J
K
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lansoprazole
- levodopa
- linezolid
- lomustine
- loncastuximab tesirine
- lovastatin
- lurbinectedin
- lyme disease vaccine
M
- mechlorethamine
- melphalan
- melphalan flufenamide
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mephenytoin
- mercaptopurine
- methotrexate
- metronidazole
- mirvetuximab soravtansine
- mitomycin
- mitoxantrone
- mixed respiratory vaccine
- monomethyl fumarate
- mosunetuzumab
- mumps skin test antigen
N
O
P
- paclitaxel
- paclitaxel protein-bound
- palifermin
- pantoprazole
- pegfilgrastim
- peginterferon alfa-2a
- peginterferon alfa-2b
- pemetrexed
- pentostatin
- pertussis, acellular
- phenytoin
- pitavastatin
- plague vaccine
- plazomicin
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- polatuzumab vedotin
- poliovirus vaccine, inactivated
- polymyxin b
- pomalidomide
- ponatinib
- pravastatin
R
- rabeprazole
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- red yeast rice
- remdesivir
- repotrectinib
- rilonacept
- roflumilast
- ropeginterferon alfa-2b
- rosuvastatin
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- ruxolitinib
S
- saccharomyces boulardii lyo
- sargramostim
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- secnidazole
- selinexor
- simvastatin
- sipuleucel-T
- skin test antigens, multiple
- smallpox and mpox vaccine
- sodium phosphate p32
- staphage lysate (spl)
- stavudine
- streptococcus salivarius
- streptomycin
- streptozocin
T
- tafasitamab
- talquetamab
- tarlatamab
- tbo-filgrastim
- teclistamab
- telavancin
- telbivudine
- temozolomide
- teniposide
- tetanus toxoid
- thioguanine
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tinidazole
- tisotumab vedotin
- tobramycin
- tocilizumab
- torsemide
- trabectedin
- trichophyton skin test
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
U
V
- valacyclovir
- valganciclovir
- vancomycin
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- vitamin e
W
Z
Carboplatin disease interactions
There are 5 disease interactions with carboplatin which include:
More about carboplatin
- carboplatin consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.